The Results Are In:
The FIRST EVER Clinical Study of VigRX Plus® With Real Men Is Now Complete...
... And The Results Are Outstanding!
In just 84 days, study participants saw:
- 62.82% INCREASE in ability to maintain erection †
- 58.97% INCREASE in ability to penetrate partner †
- 22.49% INCREASE in frequency & quality of orgasms †
- 71.43% INCREASE in sexual & intercourse satisfaction †
- 47.00% INCREASE in sex drive and desire †
- 61.00% INCREASE in overall sexual satisfaction †
Click here to read the clinical study, which has been published on BioMed Central and republished in The US National Library of Medicine and the National Institute of Health.
Results shown were from a triple-blind placebo controlled, randomized Clinical Study by Vedic Lifesciences Pvt. LTD.
For the last ten years, we've been getting feedback directly from our customers about VigRX Plus®.
So we already knew that it was extremely potent.
But we have to admit, even we were a touch surprised when we received the results of our two-year clinical study, completed by Vedic Lifesciences Pvt. Ltd.
We knew it was good.
But we didn't know it was THAT good!
If you like, you're welcome to read the 56-page clinical study report that we received directly from Vedic Lifesciences.
However, we know you're busy, so we've summarized a few of the most notable results from study participants below for your convenience:
An Explanation Of How The Study Was Conducted And Who Was Involved:
The clinical study was performed by Vedic Lifesciences Pvt. Ltd.
It was a triple-blind study, which means nobody involved in evaluating the results (doctors, researchers, etc.) knew whether participants were taking VigRX Plus® or the placebo.
The trial ran for 84 days, with assessment visits taking place on Day 28, Day 56, and Day 84.
The results were assessed using the IIEF – the International Index of Erectile Function. This system of assessment is well respected throughout the international community and has demonstrated consistent treatment responsiveness in studies in the US, Europe, and Asia. It measures:
- Erection Frequency
- Erection Firmness
- Frequency of Partner Penetration
- Frequency of Maintaining An Erection After Penetration
- Ability To Maintain An Erection To Completion Of Intercourse
- Confidence In Achieving And Maintaining An Erection
Patient and partner satisfaction was measured using the internationally recognized EDITS questionnaire.
And prior to the start of the study, the protocols and amendments were submitted to and formally approved by the Independent Institutional Ethics Commit (IEC).
Profile Of The Men Who Participated:
The 75 men who participated in the study were between the ages of 25 and 50, in monogamous, heterosexual relationships.
They agreed to take the recommended dose of VigRX Plus® – 2 capsules, twice per day with meals for 12 weeks.
Out of 108 applicants screened, 78 were recruited for participation in the trial – and 75 completed the trial.
No participants had major psychiatric disorders, a history of heart conditions, diabetes, spinal cord injuries, deformities of the penis, HIV/Aids, or sexually transmitted diseases. None were alcoholics, used medications known to causes sexual dysfunction, had liver or renal dysfunction, erection issues caused by low testosterone, or had female partners who were pregnant.
Overview Of The Most Significant Clinical Study Results
After 84 days of supplementation with VigRX Plus®, guys who participated in the trial saw a 62.82% INCREASE in their ability to keep their erection thick, full, and firm during penetration of their partner.
This was as compared to the placebo group, see the chart below:
|Ability to maintain erection after penetration (Q4 of IIEF)|
|2.56 ±1.1||4.02 ±1.62||62.82%|
|2.44 ±1.1||2.66 ±1.34||10.18%|
|IIEF scores are expressed as Mean ±2SD|
58.97% INCREASE in ability to penetrate partner †
During this study, both the patient AND their sexual partners were questioned using the EDITS scale, and their sexual satisfaction was measured and compared – VigRX Plus® vs. the placebo.
One particularly interesting result...
Female partners of patients taking VigRX Plus® reported a 58.97% INCREASE in their partner's ability to penetrate them, with dramatic improvements in their overall satisfaction!
Meanwhile, those partners of patients taking the placebo reported a DECREASE in penetration during this same period!
See the chart below:
|Ability to penetrate the partner (Q3 of IIEF)|
|2.69 ± 1.12||4.12 ± 1.6||58.97%|
|2.64 ± 1.08||2.63 ± 1.38||4.86%|
|IIEF scores are expressed as Mean ±2SD|
22.49% INCREASE in quantity of orgasms †
Compared to the placebo group, the men taking VigRX Plus® reported, over the 84 day test period, a 22.49% increase in the total number of orgasms they had.
Last we checked, more orgasms definitely equated to BETTER overall sexual satisfaction.
47.00% INCREASE in sex drive and desire †
One of the reasons VigRX Plus® was evaluated to be, potentially, superior to prescription erection medications is because it has been shown to measurably increase desire for sex.
Prescription meds just affect your erections – they don't impact your sex drive.
Yet sex drive and erection quality are LINKED!
So it stands to reason, given that VigRX Plus® has been shown to increase desire for sex by 47% as well as increase erection quality and frequency, it could be considered BETTER than prescription meds!
Men who took VigRX Plus® for the trial period also reported a 71.43% improvement in their sexual and intercourse satisfaction.
This compared to the only 12% improvement reported by those who took the placebo!
That means guys who took VigRX Plus® were almost 6 TIMES more sexually satisfied during the 84-day trial than those who took the placebo!
61.00% INCREASE in overall sexual satisfaction †
And finally when all of the results were in, after 84 days the patients taking VigRX Plus® reported a 61.00% increase in their overall sexual satisfaction...
... While the placebo group reported a DECREASE in overall satisfaction!
And don't forget: this was a triple-blind study, which means the doctors, the researchers, and the patients all had NO IDEA whether they'd taken the placebo or VigRX Plus®.
This completely eliminates any bias in the results!
Erection Quality Scores Compared Over 12 Weeks:
As you can see, over the 12 week trial period, VigRX Plus® produced measurable increases in erection quality scores, when compared to the placebo.
Study Participants Answer The Question:
“Would You Continuing Taking VigRX Plus® Or The Placebo? Yes or No?”
The Results of The Triple-Blind Study
Were Overwhelmingly Positive.
VigRX Plus® was shown to be a comparable alternative to prescription erection medications, MINUS the risk of unwanted side effects!
After 84 days of supplementation, men who’d taken VigRX Plus® were happy with the overall improvements in the sexual performance.
And Vedic Lifesciences reported that:
... A full 90% of the men who’d taken VigRX Plus® during the clinical trial chose to KEEP TAKING IT once the study was over, they were SO SATISFIED with the results!
And in another direct quote received from Vedic Lifesciences:
“In conclusion, the use of VigRX Plus® for twelve weeks was significantly better than placebo in improving erectile function in subjects with sexual dysfunction.
It was also significantly superior to the placebo in improving the other aspects of sexual health such as libido, intercourse satisfaction, orgasmic function, and overall satisfaction.
The enhancement of sexual function was endorsed by female partners of subjects receiving VigRX Plus®.
VigRX Plus® was safe and well tolerated in subjects with male sexual dysfunction!”
Other Clinical & Safety Studies Completed:
- • Side Effects of VigRX - First Study*
- • Side Effects of VigRX - Second Study*
- • Evaluation of Aphrodisiac Activity*
- • Safety, Efficacy and Purity of VigRX*
- • Rho-kinase Inhibition Assay*
- • Analysis For ED APIs*
- • Acute Oral Toxicity Study*
- • Ames Test of VigRX Tablet Blend*
*Studies done on VigRX original formula